Back to Search
NIAZ USMAN, M.D.
M.D.
Gastroenterology Physician
NPI: 1588639777IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
35066544(OH)
CMS Specialties
PrimaryGASTROENTEROLOGY
Education
OTHER
Class of 1989
Research & Publications (20)
Comparison of atherosclerotic plaque burden and composition between diabetic and non diabetic patients by non invasive CT angiography.
PMID 19633998·Int J Cardiovasc Imaging·2009
4-observational
Relations between digital thermal monitoring of vascular function, the Framingham risk score, and coronary artery calcium score.
PMID 19083982·J Cardiovasc Comput Tomogr·2008
5-case
Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
PMID 17896152·Ann Surg Oncol·2007
8-other
Chemically synthesized sugar-cholestanols possess a preferential anticancer activity involving promising therapeutic potential against human esophageal cancer.
PMID 17640296·Cancer Sci·2007
8-other
Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis.
PMID 17335543·Br J Clin Pharmacol·2007
1-meta
Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines.
PMID 17273761·Int J Oncol·2007
8-other
Prevention and treatment of cryptosporidiosis in immunocompromised patients.
PMID 17253532·Cochrane Database Syst Rev·2007
1-meta
Expression of carbohydrate antigens in human esophageal squamous cell carcinoma: prognostic application and its diagnostic implications.
PMID 17094023·Ann Surg Oncol·2007
8-other
RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.
PMID 16750623·Eur J Cancer·2006
7-preclinical
Developed world is robbing Africa of health staff: there are no easy answers.
PMID 15994695·BMJ·2005
8-other
A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors.
PMID 15956252·Mol Cancer Ther·2005
3-trial
Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors.
PMID 15906031·Cancer Chemother Pharmacol·2005
3-trial
The mammalian pannexin family is homologous to the invertebrate innexin gap junction proteins.
PMID 15028292·Genomics·2004
7-preclinical
Perceptions of influenza and influenza vaccination in patients attending hospital outpatient clinics.
PMID 12070969·Commun Dis Public Health·2002
8-other
Altering electrical connections in the nervous system of the pteropod mollusc Clione limacina by neuronal injections of gap junction mRNA.
PMID 12492443·Eur J Neurosci·2002
7-preclinical
Identification and characterization of a new family of C-type lectin-like genes from planaria Girardia tigrina.
PMID 12145187·Glycobiology·2002
4-observational
Cortical upper layer neurons derive from the subventricular zone as indicated by Svet1 gene expression.
PMID 11493521·Development·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 5 locations total
- Address
- 75 SYLVANIA DR
BEAVERCREEK, OH 45440 - Phone
- (937) 320-5050
Locations (5)
Practice Location
75 SYLVANIA DR, BEAVERCREEK, OH
(937) 320-5050
Practice Location
4200 INDIAN RIPPLE RD, BEAVERCREEK, OH
(937) 320-5050
Practice Location
4439 STATE ROUTE 159 STE 210, CHILLICOTHE, OH
(740) 779-8700
Practice Location
9000 N Main St Ste 405, Englewood, OH
(937) 320-5050
Practice Location
415 BYERS RD STE 100, MIAMISBURG, OH
(937) 320-5050
Quick Facts
- NPI
- 1588639777
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 5
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile